Evidence for somatic mutation screening on aggressive prolactinomas
Nat Rev Endocrinol
.
2024 Oct;20(10):565-566.
doi: 10.1038/s41574-024-01010-x.
Authors
Marily Theodoropoulou
1
,
Stephan Petersenn
2
3
,
Philippe Chanson
4
,
Gerald Raverot
5
Affiliations
1
Medizinische Klinik und Poliklinik IV, LMU Klinikum, LMU München, Munich, Germany. marily.theodoropoulou@med.uni-muenchen.de.
2
ENDOC Center for Endocrine Tumors, Hamburg, Germany.
3
University of Duisburg-Essen, Essen, Germany.
4
Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
5
Department of Endocrinology, Reference Centre for Rare Pituitary Diseases HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, Bron, France.
PMID:
38886618
DOI:
10.1038/s41574-024-01010-x
No abstract available
Publication types
News
MeSH terms
Genetic Testing / methods
Humans
Mutation*
Pituitary Neoplasms* / diagnosis
Pituitary Neoplasms* / genetics
Pituitary Neoplasms* / pathology
Prolactinoma* / diagnosis
Prolactinoma* / genetics